Acro Biomedical (ACBM) Non Operating Income (2018 - 2021)

Acro Biomedical has reported Non Operating Income for 4 years, with the latest figure at $1367.0 in Q2 2021.

• On a quarterly basis, Non Operating Income rose 47.31% year-over-year to $1367.0 in Q2 2021; TTM through Jun 2021 was -$1766.0, a 18.05% decrease from a year earlier, with the FY2019 full-year figure at -$1983.0, changed N/A from the prior year.
• Non Operating Income was $1367.0 for Q2 2021 at Acro Biomedical, up from -$2503.0 in the prior quarter.
• The five-year high for Non Operating Income was $1367.0 in Q2 2021, with the low at -$2503.0 in Q1 2021.
• Average Non Operating Income over 4 years is -$573.7, with a median of -$579.0 recorded in 2019.
• The sharpest annual moves came in 2020 and 2021: Non Operating Income surged 229.43% in 2020, then plunged 467.57% in 2021.
• Over 4 years, Non Operating Income stood at -$722.0 in 2018, then soared by 39.06% to -$440.0 in 2019, then tumbled by 254.09% to -$1558.0 in 2020, then soared by 187.74% to $1367.0 in 2021.
• The last three Non Operating Income figures came in at $1367.0 (Q2 2021), -$2503.0 (Q1 2021), and -$1558.0 (Q3 2020), per Business Quant data.